The breast tissue markers market size has grown strongly in recent years. It will grow from $2.99 billion in 2025 to $3.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to limited availability of tissue marker materials, reliance on traditional metallic markers, growing breast cancer diagnosis rates, increasing hospital and surgical center adoption, demand for accurate biopsy site localization.
The breast tissue markers market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of polymer-based and gelatin markers, expansion of minimally invasive biopsy procedures, rising investment in imaging-compatible tissue markers, increasing awareness of patient safety and marker biocompatibility, integration of tissue markers with advanced imaging systems. Major trends in the forecast period include increasing adoption of metal and non-metal tissue markers, rising preference for biodegradable and radiopaque markers, growth in breast cancer screening and biopsy procedures, demand for shape-specific markers for accurate localization, enhanced focus on imaging compatibility and patient safety.
The rise in the number of breast cancer cases is anticipated to support the expansion of the breast tissue markers market going forward. Breast cancer is a malignant tumor that originates in the cells of breast tissue. The increase in breast cancer cases is commonly associated with factors such as increased life expectancy, advancements in diagnostic methods, lifestyle changes, and environmental influences. Breast tissue markers are utilized in breast cancer care to assist in diagnosis, monitor disease progression, and guide treatment decisions by identifying specific proteins or genetic mutations. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, it was reported that in 2025 an estimated 316,950 women are expected to be diagnosed with invasive breast cancer, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Consequently, the rising number of breast cancer cases is strengthening the growth outlook of the breast tissue markers market.
Leading companies operating in the breast tissue markers market are focusing on developing innovative solutions, such as breast biopsy site markers, to enhance ultrasound visibility, improve ease of localization, and reduce displacement during surgical procedures. A breast biopsy site marker is a small implantable device placed at the biopsy site to mark the location for future imaging or surgical intervention. For example, in August 2023, Mammotome, a US-based provider of breast biopsy markers, introduced the HydroMARK Plus breast biopsy site marker. This marker incorporates a hydrogel design that expands upon contact with fluid, significantly enhancing ultrasound visibility. Its design supports accurate site marking and reliable localization for follow-up diagnostic and treatment procedures, while providing long-term stability within breast tissue and reducing the need for repeat interventions.
In July 2024, Hologic Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. This acquisition enables Hologic to expand its breast cancer diagnostics and treatment portfolio by integrating Endomagnetics’ advanced magnetic detection technologies. Endomagnetics Ltd. is a UK-based provider of breast tissue marker technologies.
Major companies operating in the breast tissue markers market are Johnson & Johnson Company, Medtronic PLC, Hologic Inc., Cook Medical Inc., Merit Medical Systems Inc., Argon Medical Devices Inc., Devicor Medical Products Inc., Endomag, Becton Dickinson and Company, INRAD Inc., Biopsy Sciences LLC, Carbon Medical Technologies Inc., Scion Medical Technologies LLC, SOMATEX Medical Technologies GmbH, Seno Medical Instruments Inc, Sterylab S.r.l., Biopsybell S.r.l., MDL S.r.l., SenoRx Inc, Elucent Medical, Cortex, Medax Medical Devices, Tsunami S.r.l., Ranfac Corp.
North America was the largest region in the breast tissue markers market in 2025. The regions covered in the breast tissue markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast tissue markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the breast tissue markers market by increasing the cost of imported metals such as titanium, stainless steel, and gold, as well as specialized polymers used in non-metal markers. Segments like metal markers and polymer-based markers are most impacted, particularly in regions like Asia-Pacific and North America. While tariffs have raised production and supply costs, they have also encouraged domestic manufacturing, innovation in biodegradable markers, and the development of cost-efficient alternatives, strengthening local capabilities over time.
The breast tissue markers market research report is one of a series of new reports that provides breast tissue markers market statistics, including breast tissue markers industry global market size, regional shares, competitors with a breast tissue markers market share, detailed breast tissue markers market segments, market trends and opportunities, and any further data you may need to thrive in the breast tissue markers industry. This breast tissue markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast tissue markers are small implanted devices used in breast cancer diagnosis and treatment to mark the location of a biopsy site, tumor, or suspicious area within the breast. They are typically placed during biopsy procedures to allow accurate identification of the site during future imaging, surgery, or treatment.
The main product types of breast tissue markers include metal and non-metal markers. Metal breast tissue markers are small metallic markers, commonly made of materials such as stainless steel, used to accurately locate and monitor breast tumors. The materials include non-biodegradable and partially biodegradable options, and the shapes include coil, ribbon, butterfly, V-shape, and others. These markers are used by end users such as hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics.
The breast tissue markers consist of sales of radiofrequency identification (RFID) markers, magnetic markers, ultrasound-visible markers, and hydrogel markers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The breast tissue markers market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of polymer-based and gelatin markers, expansion of minimally invasive biopsy procedures, rising investment in imaging-compatible tissue markers, increasing awareness of patient safety and marker biocompatibility, integration of tissue markers with advanced imaging systems. Major trends in the forecast period include increasing adoption of metal and non-metal tissue markers, rising preference for biodegradable and radiopaque markers, growth in breast cancer screening and biopsy procedures, demand for shape-specific markers for accurate localization, enhanced focus on imaging compatibility and patient safety.
The rise in the number of breast cancer cases is anticipated to support the expansion of the breast tissue markers market going forward. Breast cancer is a malignant tumor that originates in the cells of breast tissue. The increase in breast cancer cases is commonly associated with factors such as increased life expectancy, advancements in diagnostic methods, lifestyle changes, and environmental influences. Breast tissue markers are utilized in breast cancer care to assist in diagnosis, monitor disease progression, and guide treatment decisions by identifying specific proteins or genetic mutations. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, it was reported that in 2025 an estimated 316,950 women are expected to be diagnosed with invasive breast cancer, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Consequently, the rising number of breast cancer cases is strengthening the growth outlook of the breast tissue markers market.
Leading companies operating in the breast tissue markers market are focusing on developing innovative solutions, such as breast biopsy site markers, to enhance ultrasound visibility, improve ease of localization, and reduce displacement during surgical procedures. A breast biopsy site marker is a small implantable device placed at the biopsy site to mark the location for future imaging or surgical intervention. For example, in August 2023, Mammotome, a US-based provider of breast biopsy markers, introduced the HydroMARK Plus breast biopsy site marker. This marker incorporates a hydrogel design that expands upon contact with fluid, significantly enhancing ultrasound visibility. Its design supports accurate site marking and reliable localization for follow-up diagnostic and treatment procedures, while providing long-term stability within breast tissue and reducing the need for repeat interventions.
In July 2024, Hologic Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. This acquisition enables Hologic to expand its breast cancer diagnostics and treatment portfolio by integrating Endomagnetics’ advanced magnetic detection technologies. Endomagnetics Ltd. is a UK-based provider of breast tissue marker technologies.
Major companies operating in the breast tissue markers market are Johnson & Johnson Company, Medtronic PLC, Hologic Inc., Cook Medical Inc., Merit Medical Systems Inc., Argon Medical Devices Inc., Devicor Medical Products Inc., Endomag, Becton Dickinson and Company, INRAD Inc., Biopsy Sciences LLC, Carbon Medical Technologies Inc., Scion Medical Technologies LLC, SOMATEX Medical Technologies GmbH, Seno Medical Instruments Inc, Sterylab S.r.l., Biopsybell S.r.l., MDL S.r.l., SenoRx Inc, Elucent Medical, Cortex, Medax Medical Devices, Tsunami S.r.l., Ranfac Corp.
North America was the largest region in the breast tissue markers market in 2025. The regions covered in the breast tissue markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast tissue markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the breast tissue markers market by increasing the cost of imported metals such as titanium, stainless steel, and gold, as well as specialized polymers used in non-metal markers. Segments like metal markers and polymer-based markers are most impacted, particularly in regions like Asia-Pacific and North America. While tariffs have raised production and supply costs, they have also encouraged domestic manufacturing, innovation in biodegradable markers, and the development of cost-efficient alternatives, strengthening local capabilities over time.
The breast tissue markers market research report is one of a series of new reports that provides breast tissue markers market statistics, including breast tissue markers industry global market size, regional shares, competitors with a breast tissue markers market share, detailed breast tissue markers market segments, market trends and opportunities, and any further data you may need to thrive in the breast tissue markers industry. This breast tissue markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast tissue markers are small implanted devices used in breast cancer diagnosis and treatment to mark the location of a biopsy site, tumor, or suspicious area within the breast. They are typically placed during biopsy procedures to allow accurate identification of the site during future imaging, surgery, or treatment.
The main product types of breast tissue markers include metal and non-metal markers. Metal breast tissue markers are small metallic markers, commonly made of materials such as stainless steel, used to accurately locate and monitor breast tumors. The materials include non-biodegradable and partially biodegradable options, and the shapes include coil, ribbon, butterfly, V-shape, and others. These markers are used by end users such as hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics.
The breast tissue markers consist of sales of radiofrequency identification (RFID) markers, magnetic markers, ultrasound-visible markers, and hydrogel markers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Breast Tissue Markers Market Characteristics
3. Breast Tissue Markers Market Supply Chain Analysis
4. Global Breast Tissue Markers Market Trends and Strategies
5. Breast Tissue Markers Market Analysis of End Use Industries
7. Global Breast Tissue Markers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Breast Tissue Markers Total Addressable Market (TAM) Analysis for the Market
9. Breast Tissue Markers Market Segmentation
10. Breast Tissue Markers Market Regional and Country Analysis
11. Asia-Pacific Breast Tissue Markers Market
12. China Breast Tissue Markers Market
13. India Breast Tissue Markers Market
14. Japan Breast Tissue Markers Market
15. Australia Breast Tissue Markers Market
16. Indonesia Breast Tissue Markers Market
17. South Korea Breast Tissue Markers Market
18. Taiwan Breast Tissue Markers Market
19. South East Asia Breast Tissue Markers Market
20. Western Europe Breast Tissue Markers Market
21. UK Breast Tissue Markers Market
22. Germany Breast Tissue Markers Market
23. France Breast Tissue Markers Market
24. Italy Breast Tissue Markers Market
25. Spain Breast Tissue Markers Market
26. Eastern Europe Breast Tissue Markers Market
27. Russia Breast Tissue Markers Market
28. North America Breast Tissue Markers Market
29. USA Breast Tissue Markers Market
30. Canada Breast Tissue Markers Market
31. South America Breast Tissue Markers Market
32. Brazil Breast Tissue Markers Market
33. Middle East Breast Tissue Markers Market
34. Africa Breast Tissue Markers Market
36. Breast Tissue Markers Market Competitive Landscape and Company Profiles
37. Breast Tissue Markers Market Other Major and Innovative Companies
40. Breast Tissue Markers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Breast Tissue Markers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses breast tissue markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for breast tissue markers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast tissue markers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Metal; Non-metal2) By Material: Non-biodegradable; Partially Biodegradable
3) By Shape: Coil; Ribbon; Butterfly; V-Shape; Other Shapes
4) By End-user: Hospitals; Ambulatory; Surgical Centers; Diagnostic Centers; Specialty Clinics
Subsegments:
1) By Metal: Titanium Markers; Stainless Steel Markers; Gold Markers2) By Non-Metal: Biodegradable Markers; Radiopaque Markers; Polymer-Based Markers; Gelatin Markers
Companies Mentioned: Johnson & Johnson Company; Medtronic PLC; Hologic Inc.; Cook Medical Inc.; Merit Medical Systems Inc.; Argon Medical Devices Inc.; Devicor Medical Products Inc.; Endomag; Becton Dickinson and Company; INRAD Inc.; Biopsy Sciences LLC; Carbon Medical Technologies Inc.; Scion Medical Technologies LLC; SOMATEX Medical Technologies GmbH; Seno Medical Instruments Inc; Sterylab S.r.l.; Biopsybell S.r.l.; MDL S.r.l.; SenoRx Inc; Elucent Medical; Cortex; Medax Medical Devices; Tsunami S.r.l.; Ranfac Corp
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Breast Tissue Markers market report include:- Johnson & Johnson Company
- Medtronic PLC
- Hologic Inc.
- Cook Medical Inc.
- Merit Medical Systems Inc.
- Argon Medical Devices Inc.
- Devicor Medical Products Inc.
- Endomag
- Becton Dickinson and Company
- INRAD Inc.
- Biopsy Sciences LLC
- Carbon Medical Technologies Inc.
- Scion Medical Technologies LLC
- SOMATEX Medical Technologies GmbH
- Seno Medical Instruments Inc
- Sterylab S.r.l.
- Biopsybell S.r.l.
- MDL S.r.l.
- SenoRx Inc
- Elucent Medical
- Cortex
- Medax Medical Devices
- Tsunami S.r.l.
- Ranfac Corp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.24 Billion |
| Forecasted Market Value ( USD | $ 4.43 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
